Carisoprodol is a prescription muscle relaxant primarily indicated for the treatment of chronic back pain and must be dispensed under medical supervision. It is associated with adverse effects such as dizziness, drowsiness, nausea, and cognitive impairment. Furthermore, overdose poses significant toxicity risks, and the drug carries a notable potential for abuse.

To support law enforcement efforts, AccuSift provides high-performance competitive antibody pairs for carisoprodol detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.